Prism Peptides
SS-31
SS-31
Couldn't load pickup availability
đ´ IMPORTANT: Read This Before Proceeding With Dosing
đ§Ź SS-31 (Elamipretide)
Mitochondrial Repair ⢠Cellular Energy ⢠Longevity Support
SS-31 is a mitochondrial-targeted peptide designed to restore and protect mitochondrial functionâthe core energy systems of the bodyâs cells. By stabilizing cardiolipin, a critical lipid in mitochondrial membranes, SS-31 helps improve cellular energy production while reducing oxidative stress and inflammation.
Unlike many peptides that target hormones or appetite pathways, SS-31 works directly inside the mitochondria, helping restore cellular performance and resilience.
It is widely studied for aging, metabolic health, cardiovascular function, neurological protection, and energy optimization.
âď¸ Mechanism of Action
SS-31 works by binding to cardiolipin, a phospholipid located in the inner mitochondrial membrane.
This action:
⢠Stabilizes mitochondrial membranes
⢠Improves ATP energy production
⢠Reduces oxidative stress
⢠Improves mitochondrial efficiency
⢠Prevents mitochondrial dysfunction
Healthy mitochondria are essential for metabolism, brain function, muscle performance, and longevity.
⨠Benefits
⢠Improves cellular energy production (ATP)
⢠Supports healthy aging and longevity
⢠Protects mitochondria from oxidative stress
⢠Improves cardiovascular function
⢠Supports brain health and cognitive performance
⢠Enhances muscle endurance and recovery
⢠Improves metabolic efficiency
⢠May help reduce fatigue and age-related decline
⢠Supports vision and retinal health
â ď¸ Possible Side Effects
⢠Injection site irritation
⢠Mild fatigue
⢠Headache
⢠Temporary nausea
Side effects are typically mild and uncommon.
đŤ Contraindications
Do not use if:
⢠Pregnant or breastfeeding
⢠Allergic to peptide compounds
đ RECONSTITUTION GUIDE
SS-31 50 mg vial
Reconstitution: 3 mL BAC water
Concentration: 1 mg â 6 units
Administration: Subcutaneous
đ Titration Schedule
Weeks 1â2 (Adaptation Phase)
30 units (5 mg)
3Ă per week
Supports mitochondrial activation while allowing the body to adapt.
Weeks 3â4 (Build Phase)
40 units (â6.5 mg)
4Ă per week
Improves mitochondrial function and cellular energy production.
Weeks 5â6 (Therapeutic Phase)
50 units (â8 mg)
5Ă per week
Enhances mitochondrial repair and oxidative stress reduction.
Weeks 7â8 (Maximum Phase)
60â65 units (10 mg)
Daily
Maximizes mitochondrial restoration and metabolic support.
đ Cycle Duration
8 weeks ON
3 weeks OFF
đ Injection Guidelines
⢠Subcutaneous injection
⢠Belly fat or thigh area
⢠Inject in a fasted state
⢠Rotate injection sites
đ Stacking Recommendation
Best used before MOTS-C cycles to prime mitochondria.
SS-31 â improves mitochondrial structure
MOTS-C â improves metabolic signaling
Together they provide stronger metabolic and longevity benefits.
